|
Aug 29
|
Immuneering to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
|
|
Aug 28
|
Favourable Signals For Immuneering: Numerous Insiders Acquired Stock
|
|
Jan 9
|
With 37% ownership, Immuneering Corporation (NASDAQ:IMRX) has piqued the interest of institutional investors
|
|
Nov 29
|
Here's Why We're Watching Immuneering's (NASDAQ:IMRX) Cash Burn Situation
|
|
Oct 4
|
Immuneering to Present Preclinical Data on IMM-1-104 and IMM-6-415 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
|